Athanor Capital’s ChemoCentryx, Inc. CCXI Stock Holding History

Athanor Capital’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,293	Closed	-$374K	–	945
2021 Q1	$374K	Sell	7,293 -11,172	-61%	-$672K	0.01%	544
2020 Q4	$1.14M	Buy	18,465 +8,107	+78%	+$464K	0.03%	289
2020 Q3	$568K	Sell	10,358 -19,328	-65%	-$1.04M	0.02%	315
2020 Q2	$1.71M	Buy	+29,686	New	+$1.62M	0.09%	126
2020 Q1	–	Sell	-32,434	Closed	-$1.28M	–	394
2019 Q4	$1.28M	Buy	+32,434	New	+$570K	0.06%	138

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Athanor Capital's CCXI Position: Q2 2021 in Review

Athanor Capital sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 7,293 shares — an estimated $374K sold.

Athanor Capital first reported a position in CCXI in Q4 2019 and held it in 5 quarters. The position peaked at $1.71M in Q2 2020. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

Athanor Capital reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
Athanor Capital sold 7,293 ChemoCentryx, Inc. shares in Q2 2021, an estimated $374K.
Athanor Capital first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 5 quarters.
Athanor Capital's ChemoCentryx, Inc. position peaked at $1.71M in Q2 2020.
146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.